Northern Territory First Nations children receive effective vaccine to reduce infection-induced hearing loss

Hearing loss prevalence (none, mild, moderate, severe) by booster dose, at ages 12 (baseline), 18 (primary endpoint), 24, 30, and 36 months. Credit: PLOS Medicine (2024). DOI: 10.1371/journal.pmed.1004375 A study led by Menzies School of Health Research has uncovered that Northern Territory (NT) First Nations children aged 12–36 months have access to an effective vaccine that could prevent hearing loss. Published in PLOS Medicine, this five-year study looked to uncover which type of pneumococcal conjugate vaccine (PCV), +P or +S, could best reduce debilitating hearing loss caused by chronic otitis Read More

Related posts:

  1. Legacy of vaccine hesitancy may be leaving workers vulnerable to measles infection and spread
  2. Chemo drug may cause significant hearing loss in longtime cancer survivors
  3. ‘I keep away from people’—combined vision and hearing loss is isolating more and more older Australians
  4. Positive leadership communication can be an effective tool to reduce worker burnout, turnover
  5. Scientists identify a positive molecular feedback loop which could explain stroke-induced memory loss
  6. Program supporting psychological well-being and parenting skills of mothers of children with ADHD proves effective
  7. HMN: 7 safe and effective weight-loss pills in 2025
  8. Older weight loss drugs are in demand. But are they safe or effective? And should you take them?

Leave a Reply

Your email address will not be published. Required fields are marked *